Literature DB >> 2655052

[Severe mixed hepatitis caused by fenofibrate? A review of the literature apropos of a case].

J Rigal1, Y Furet, E Autret, M Breteau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2655052     DOI： 10.1016/s0248-8663(89)80119-5

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN： 0248-8663            Impact factor:   0.728


× No keyword cloud information.
  4 in total

Review 1.  Fenofibrate-induced cirrhosis.

Authors:  Furqaan Ahmed; Lydia Petrovic; Ellen Rosen; Raimundo Gonzalez; Ira M Jacobson
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 2.  Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.

Authors:  J A Balfour; D McTavish; R C Heel
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

3.  Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database.

Authors:  Shizhan Ma; Shudong Liu; Qi Wang; Lijuan Chen; Ping Yang; Huihuan Sun
Journal:  J Clin Pharm Ther       Date:  2019-09-13       Impact factor: 2.512

4.  Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.

Authors:  Amr A A Mahmoud; Shimaa M Elshazly
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.